Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Question 1

Who is sponsoring NCT05213195?

Accepted Answer

NCT05213195 is sponsored by Zhejiang University.

Question 2

What condition does NCT05213195 study?

Accepted Answer

NCT05213195 studies Refractory Metastatic Colorectal Cancer.

Question 3

What drugs are being tested in NCT05213195?

Accepted Answer

Interventions: NKG2D CAR-NK.

Question 4

What is the status of NCT05213195?

Accepted Answer

NCT05213195 is currently UNKNOWN.

Question 5

How many participants are in NCT05213195?

Accepted Answer

38 participants.

Lead sponsor	Zhejiang University
Phase	PHASE1
Status	UNKNOWN
Enrolment	38
Start date	Fri Dec 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Details

Conditions

Interventions

Countries